I have worked as a freelance writer and editor for more than ten years. of peer-reviewed publications including, but not limited to The Lancet, PLoS One, and Nature. The many topics that I have covered include surgery, oncology, internal
2020-08-14 · Editorial Coordinators Aislinn Boyter Ethan Feinstein Travis Griffin Amy King Christine Melchione Director, Journal Production Julie Blum Associate Director, Journal Production Catherine Forrest Associate Director, Digital Content Adrienne White Administrator, Digital Content Emilia Capuzzi Editorial & Publications Offices 2318 Mill Road, Suite 800
Editorial Full text access E-cigarettes—new product, old tricks. The Lancet Oncology. Page 1543 Yale Cancer Center Precision Medicine Tumor Board: one tumour Article Advance supports a selection of journals within Elsevier’s Oncology Journal Network. With over 50+ titles, including The Lancet Oncology , Cancer Cell, Annals of Oncology and European Journal of Cancer , our oncology network provides breadth and depth of coverage from basic to translational to clinical research, across all cancer types, with a wide variety of open access options.
(2013) The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers.Submitted: 1. 7 dec. 2017 — Lancet Oncol. 2017 Thomé B. HM, editor. Lancet. Oncol.
Vi behöver satsa på ”förstasideslayout”, ”Editor´s choice”,. ”Koll på läget” etc. Vi skall tänka i Lancet Oncol 2009;10:247–257. 21 Wang X, Jones TD, Zhang S,
Department of Oncology Nursing. University of Dundee, Scotland. Segundo Mesa. Department of Neurology.
Title: Sequential paclitaxel followed by UFT or S-1 versus UFT or S-1 alone as adjuvant chemotherapy for T4a/b gastric cancer: The SAMIT randomised trial Article Type: Articles (Clinical Trials) Abstract: Background The prognosis of locally advanced
2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of Dr Ali Landman has been Deputy Editor of The Lancet Oncology since March, 2019.She earned her PhD in Cancer Biology from MIT (Cambridge, MA, USA) in 2009, and pursued post-doctoral research in cancer biology at the University of California San Francisco, University College London, and MRC Harwell, before joining The Lancet Oncology in January, 2015, as a Senior Editor.
Editorial Full text access E-cigarettes—new product, old tricks. The Lancet Oncology. Page 1543 Yale Cancer Center Precision Medicine Tumor Board: one tumour
Article Advance supports a selection of journals within Elsevier’s Oncology Journal Network. With over 50+ titles, including The Lancet Oncology , Cancer Cell, Annals of Oncology and European Journal of Cancer , our oncology network provides breadth and depth of coverage from basic to translational to clinical research, across all cancer types, with a wide variety of open access options. Horbinski is an Associate Editor of Neuro-Oncology and Neuro-Oncology Advances, and is on the editorial board of the top three neuropathology journals (Acta Neuropathologica, Brain Pathology, Journal of Neuropathology and Experimental Neurology) and reviews for over 20 journals, including Neuro-Oncology, Oncotarget, Lancet Oncology, Cancer Research, and Clinical Cancer Research.
Hörsalen stadsbiblioteket göteborg
If you are an administrator for The Lancet Oncology, please get in touch to find out how you can verify the contributions of your editorial board members and more. CiteScore: 16.8 ℹ CiteScore: 2019: 16.8 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of Title: Sequential paclitaxel followed by UFT or S-1 versus UFT or S-1 alone as adjuvant chemotherapy for T4a/b gastric cancer: The SAMIT randomised trial Article Type: Articles (Clinical Trials) Abstract: Background The prognosis of locally advanced CiteScore: 19.4 ℹ CiteScore: 2019: 19.4 CiteScore measures the average citations received per peer-reviewed document published in this title.
In 2013 and 2015, The Lancet Oncology published two Commissions that highlighted the cancer landscape in Latin America and how it differed from more developed countries. The reports showed that funding for health care was just a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. The Lancet Psychiatry is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.
Ahmad reza parsa
vårdcentralen dalby läkare
tellus fonder alla bolag
ont i brostet nar jag ror mig
electrolux products
Elsevier.com visitor survey. We are always looking for ways to improve customer experience on Elsevier.com. We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
2019 — Lancet Oncol.